Is GHK-Cu safe?
Topically, the record is long and benign. Injected, nobody has run the study.
Collagen Synthesis & Matrix Remodeling
Glycyl-L-Histidyl-L-Lysine Copper(II) Complex
Last reviewed: August 2026
GHK-Cu is a naturally occurring tripeptide — just three amino acids — that your body produces on its own. It's been found in human blood, saliva, and urine, and its levels decline significantly with age. The 'Cu' stands for copper, which the peptide carries and delivers to cells that need it.
GHK-Cu is studied for its ability to activate collagen production and remodel the extracellular matrix — essentially the structural scaffolding that gives skin its firmness and elasticity. Think of it as a renovation signal: it tells fibroblasts (the cells that build skin structure) to produce more collagen, elastin, and other structural proteins, while simultaneously helping to break down and replace old, damaged tissue.
Collagen production drops by about 1% per year after age 20, and by the time most people are in their 40s, the visible effects are significant. GHK-Cu is one of the few compounds with a credible, well-researched mechanism for directly stimulating collagen synthesis — not just slowing its breakdown. It also has a remarkably strong safety profile, having been used in cosmetic formulations for decades.
GHK-Cu has one of the most robust research foundations of any anti-aging peptide, including published human skin studies. It's unique in having both a clear biological mechanism and decades of real-world cosmetic safety data. Purgo Labs supplies it in research-grade lyophilized form for laboratory use only.
GHK-Cu — the copper(II) complex of the tripeptide glycyl-L-histidyl-L-lysine — is one of the most extensively studied naturally occurring peptides in the field of skin biology and regenerative research. First isolated from human plasma in 1973 by Loren Pickart, GHK was initially identified as a factor that promoted liver cell survival in culture.
The peptide occurs naturally in human plasma, saliva, and urine, with plasma concentrations declining significantly with age — from approximately 200 ng/mL in young adults to roughly 80 ng/mL by age 60. This age-related decline has generated considerable scientific interest in GHK-Cu as a research model for studying the molecular mechanisms of skin aging and tissue maintenance.
GHK-Cu is a tripeptide-metal complex consisting of three amino acids — glycine, histidine, and lysine — chelated to a copper(II) ion (Cu²⁺). The histidine residue is primarily responsible for copper coordination, with its imidazole nitrogen providing the key binding site. The resulting complex has a molecular weight of approximately 403.9 Daltons.
The copper component is not merely structural — it is functionally essential. Copper is a required cofactor for lysyl oxidase, the enzyme responsible for cross-linking collagen and elastin fibers in the extracellular matrix. It is also a cofactor for superoxide dismutase (SOD), a critical antioxidant enzyme.
GHK-Cu stimulates collagen synthesis and skin repair by activating copper-dependent enzymes and upregulating growth factors that remodel the extracellular matrix.
GHK-Cu exerts its effects through multiple, partially overlapping mechanisms that collectively promote extracellular matrix synthesis, remodeling, and cytoprotection. The primary mechanism involves stimulation of collagen and elastin synthesis in dermal fibroblasts. In vitro studies have demonstrated that GHK-Cu increases the production of collagen types I, III, and IV, as well as elastin and glycosaminoglycans.
A second major mechanism involves the regulation of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs). GHK-Cu upregulates MMP-2 (gelatinase A) while simultaneously increasing TIMP-1 expression, suggesting a role in balanced matrix remodeling rather than simple matrix deposition.
Perhaps most intriguingly, research using the Broad Institute Connectivity Map demonstrated that GHK peptide modulates the expression of over 4,000 human genes, including pathways involved in DNA repair, antioxidant defense, anti-inflammatory signaling, and stem cell activation.

Stimulates fibroblast production of collagen types I, III, and IV, elastin, and glycosaminoglycans — the structural scaffold of dermal tissue.
Upregulates MMP-2 and TIMP-1 in a balanced manner, enabling controlled matrix remodeling and reduction of hypertrophic scar formation.
Resets pathological gene expression patterns across >4,000 genes, including DNA repair, antioxidant defense, and anti-inflammatory pathways.
Delivers bioavailable Cu²⁺ as cofactor for lysyl oxidase (collagen cross-linking) and superoxide dismutase (antioxidant defense).
Each outcome rated by the highest level of evidence available. Tiers follow our 5-tier methodology.
Study counts reflect peer-reviewed publications in the evidence database below. "Theoretical" outcomes have mechanistic rationale only. Learn about our evidence tiers →
1 cited study — model, sample size, outcome, and effect size from published literature.
| Study | Model | Sample | Outcome | Effect Size | Level |
|---|---|---|---|---|---|
Pickart L & Margolina A. (2018) Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the Ne… PubMed | Review — in vitro + human | Review | GHK-Cu modulates 4,000+ genes; promotes collagen I/III synthesis; anti-inflammatory | Collagen synthesis increase: 70–100% in fibroblast cultures | In Vitro |
GHK-Cu (Copper Peptide) — half-life, bioavailability, onset, and duration data
| Parameter | Value | Source |
|---|---|---|
| Half-Life (t½) | ~30–60 minutes (estimated) Rapidly degraded; topical application has different kinetics | Preclinical Data |
| Time to Peak (Tmax) | ~30–60 minutes (SC) Preclinical estimates | Preclinical Data |
| Bioavailability (F) | Topical: variable; SC: estimated >70% Topical penetration depends on formulation | Preclinical Data |
| Onset of Action | Days to weeks Collagen synthesis and tissue remodeling effects are cumulative | — |
| Duration of Action | Tissue effects persist beyond plasma half-life | — |
Naturally occurring copper-binding tripeptide (Gly-His-Lys). Endogenous levels decline with age. Topical formulations are widely used for skin applications; SC injection used for systemic tissue repair protocols.
References:
• Pickart L & Margolina A. Biomolecules 2018
• Pickart L. J Biomater Sci Polym Ed 2008
Peer-reviewed literature supporting the research profile of GHK-Cu
The following peer-reviewed studies form the primary evidence base for GHK-Cu's research profile. All references are sourced from PubMed, NCBI, and peer-reviewed scientific journals. Published research is available through PubMed, NCBI, and peer-reviewed biomedical journals.
Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. International Journal of Molecular Sciences. 2018.PMID: 29986520
GHK-Cu modulates over 4,000 human genes, including those controlling tissue remodeling and anti-inflammatory pathways.
Pickart L. The human tri-peptide GHK and tissue remodeling. Journal of Biomaterials Science, Polymer Edition. 2008.PMID: 18644225
Comprehensive review of GHK-Cu's role in collagen synthesis, wound healing, and skin remodeling.
Gorouhi F, Maibach HI. Role of topical peptides in preventing or treating aged skin. International Journal of Cosmetic Science. 2009.PMID: 19570099
Topical peptides including GHK-Cu demonstrate measurable improvements in skin firmness and wrinkle depth.
Pickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. BioMed Research International. 2015.PMID: 26236730
GHK-Cu activates TGF-β1 and promotes fibroblast proliferation and collagen production.
Skin & Anti-Aging Research
Purgo Labs list price, read 12 Sep 2026 · per-lot COA on the vendor page
50mg $29.99 → $23.99 with code HEALTH (20% off; price read 1 Nov 2026)
Fast FedEx shipping · Discreet packaging
View full legal status guide →
6 documented interactions for GHK-Cu
Both promote wound healing and collagen synthesis via complementary mechanisms — BPC-157 via angiogenesis, GHK-Cu via collagen cross-linking.
Both support tissue remodeling and wound healing via different mechanisms — TB-500 via actin modulation, GHK-Cu via collagen synthesis.
Epithalon activates telomerase for cellular longevity; GHK-Cu supports collagen synthesis and tissue remodeling. Complementary anti-aging mechanisms.
Interaction data is based on published research, known pharmacological mechanisms, and clinical practitioner experience. Evidence tiers: Clinical = human data; Emerging = preclinical/case reports; Theoretical = mechanism-based inference. Always consult a qualified healthcare provider before combining compounds.
Source GHK-Cu at Purgo Labs
50mg $29.99 list · $23.99 with code HEALTH · lab-verifiable COA per lot
Human data exist for TOPICAL use (cosmetic studies); none for injection
GHK-Cu is one of the few peptides here with human safety data — for topical use, where decades of cosmetic studies report good tolerability with occasional irritation. Injectable GHK-Cu has no human trial. The difference matters: injection delivers a copper load that a cream does not.
Research-use information only. Research-grade GHK-Cu is not an approved medicine; where trial or label figures appear below they belong to the pharmaceutical product studied, not to any research vial. This section does not give dosing or medical advice.
Every rate carries its source. Where no source exists, no rate is printed.
| Effect | Rate (sourced) | Detail | Source |
|---|---|---|---|
| Topical: mild irritation, redness | not quantified | Occasional in cosmetic studies; otherwise well tolerated. | Pickart & Margolina 2018 (review) |
| Injectable: injection-site irritation | not quantified | Plausible from the copper complex; unquantified. | General |
Regulatory status: Cosmetic ingredient; not approved as a drug anywhere.
Everything above describes GHK-Cu the molecule. The risk specific to a research vial is different: it may not contain GHK-Cu at the labelled amount, and it may contain what the synthesis left behind. Identity (mass spectrometry), purity (HPLC), measured net content and an endotoxin result are the four lines on a certificate that bear on adverse effects, and only a certificate you can check at the laboratory tells you any of them. This is what we have verified for GHK-Cu so far.
42 of the 105 vendors on our scoreboard list GHK-Cu with a price we read on the product page (11 Sep 2026–1 Nov 2026). Of those, 38 name their testing laboratory, 31 publish certificates that resolve on the lab's own site, and 36 publish measured milligrams against the label. The full ranking, with every dated price, is on Best GHK-Cu Vendors.
| Vendor | Rubric | Lab named | Price read |
|---|---|---|---|
| MyPurePeptidepartner | 10/10 | Janoshik Analytical | $35.00 · 100mg · 1 Nov 2026 |
| Oneday Compoundspartner | 10/10 | ILS Laboratories (San Diego, CA) | $20.99 · 50mg · 29 Oct 2026 |
| Panda Peptides | 10/10 | Janoshik Analytical · ILS Labs (per batch) | $26.87 · 50mg · 25 Oct 2026 |
| Peptide Giantspartner | 10/10 | Janoshik Analytical · Vanguard Laboratory | $25.00 · 50mg · 1 Nov 2026 |
| Premier Bio Labs | 10/10 | ILS Laboratories + Freedom Diagnostics | $21.98 · 50mg · 1 Nov 2026 |
Top 5 by rubric score; 37 more on the ranking page.
None yet for GHK-Cu specifically. The COA library holds the certificates we have read for each vendor on other compounds, which is the next best signal of how that vendor documents a lot.
Topically, the record is long and benign. Injected, nobody has run the study.
Side-effect section last reviewed 2026-09-12. Moved from the standalone side-effects page on 10 October 2026; text unchanged.
GHK-Cu (copper peptide) is legal to purchase and possess in the United States as a research chemical. It is widely used in cosmetic formulations and is not a controlled substance. It is not FDA-approved as a drug for human use.
| Jurisdiction | Status as stated |
|---|---|
| United States | Legal as a research chemical. Not a scheduled substance. Widely used in cosmetic products. Not FDA-approved as a drug. |
| Canada | Not a scheduled substance. Available for research and cosmetic use. Not approved by Health Canada as a drug. |
| United Kingdom | Not listed under the Misuse of Drugs Act. Available for research and cosmetic use. |
| Australia | Not scheduled by the TGA. Available for research and cosmetic use. |
| European Union | Widely used in cosmetic formulations across EU member states. Not approved as a medicinal product by the EMA. |
Statements above are as our legal-status page for GHK-Cu stated them in 2025; they were moved here on 10 October 2026 and were not re-verified in the move. Regulations change. This is general information, not legal advice; check the current position with your own jurisdiction's regulator before relying on it.
No. GHK-Cu is not a controlled substance in the United States or in most other countries.
Yes. GHK-Cu is widely available as a research chemical and is also used in cosmetic formulations. It is legal to purchase in the United States.
GHK-Cu is not specifically listed on the WADA prohibited list as of 2025. However, athletes should verify current WADA guidelines before use.
GHK-Cu is used in both cosmetic products and research settings. Cosmetic-grade GHK-Cu is formulated for topical use, while research-grade is intended for laboratory research.
Injectable GHK-Cu is not FDA-approved for human use. It is available as a research chemical for laboratory research purposes only.
GHK-Cu has more published human skin data than most research peptides, including a double-blind RCT showing improvements in skin laxity and fine lines. It is also used in FDA-cleared wound healing devices. Evidence for systemic or non-dermatological effects remains preclinical.
Purgo Labs offers GHK-Cu with ≥99% purity, third-party certificates of analysis, and fast FedEx shipping. This is an affiliate link — we may earn a commission at no cost to you.